Press Releases on November 5, 2019 - EIN Presswire - Press Release Distribution Service

Published on November 5, 2019 - 21:05 GMT

Lightbridge Reports Financial Results for the Third Quarter of 2019 and Provides Business Update on Enfission and Other ...

RESTON, Va., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ: LTBR), a nuclear fuel developer, today provided a business update and reported financial results for the third quarter ended September 30, 2019. Seth Grae, President & …

Distribution channels: Business & Economy ...

Published on November 5, 2019 - 21:05 GMT

Codexis Reports Third Quarter 2019 Financial Results

Total revenues rose 29% to $21.9 million driven by strength in R&D, product, and CodeEvolver® licensing revenues Eleven customers each contributed at least a quarter million dollars in revenue Conference call begins at 4:30 pm Eastern time today …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Devon Energy Reports Third-Quarter 2019 Results

OKLAHOMA CITY, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today reported operational and financial results for the third quarter of 2019. The company’s earnings release, supplemental financial tables and related operations report can …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019

MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) today announced that it will report third quarter financial results on Friday, November 8, 2019. Recro's management team will host a conference call and audio webcast at …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2019 - 21:05 GMT

FuelCell Energy Announces End of Engagement with Huron Based on Progress

DANBURY, Conn., Nov. 05, 2019 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced that based on the …

Distribution channels: Electronics Industry, Media, Advertising & PR ...

Published on November 5, 2019 - 21:05 GMT

Chiasma Reports Third Quarter 2019 Results

CHIASMA OPTIMAL trial, conducted under SPA and designed to support FDA approval, met the primary and all secondary endpoints MYCAPSSA® NDA on track for submission by year-end 2019 MPOWEREDTM Phase 3 trial, designed to support EU approval, progressing as …

Distribution channels: Business & Economy ...

Published on November 5, 2019 - 21:05 GMT

Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress

First Patients Treated with FT516, an Off-the-Shelf NK Cell Cancer Immunotherapy for AML and for B-cell Lymphoma in Combination with Rituximab Received FDA Clearance of IND Application for FT596, an Off-the-Shelf, Multi-Antigen Targeted CAR NK Cell Product …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Lilis Energy to Report Third Quarter 2019 Operating and Financial Results on Thursday, November 7, 2019 and Provide Corporate ...

Conference Call To Be Held Friday, November 8, 2019 At 11:00 AM Eastern Time FORT WORTH, Texas, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Lilis Energy, Inc. (NYSE American: LLEX), an exploration and development company operating in the Permian Basin of West Texas …

Distribution channels: Culture, Society & Lifestyle

Published on November 5, 2019 - 21:05 GMT

Adesto® Reports Third Quarter 2019 Financial Results

SANTA CLARA, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Adesto Technologies Corporation (NASDAQ: IOTS), a leading provider of innovative application-specific semiconductors and embedded systems for the IoT, today announced financial results with record …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Fluidigm Announces Third Quarter 2019 Financial Results

Third quarter revenue decreased 8.5 percent to $26.5 million; year-to-date revenue increased 5 percent to $84.8 million Third quarter consumables revenue increased 11 percent Year-to-date mass cytometry revenue increased 28 percent More than 10 new …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Mohawk Group Reports Third Quarter 2019 Results

NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk” or the “Company”) today announced results for the third quarter ended September 30, 2019. 3 new products launched in the third quarter and 17 new product …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2019 - 21:05 GMT

OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results

MIAMI, Nov. 05, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2019. Business Highlights Somatrogon meets primary and key secondary endpoints in global …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Century Aluminum Company Reports Third Quarter 2019 Results

CHICAGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its third quarter 2019 results. Third Quarter 2019 Financial Results Shipments of 198,543 tonnes, a 2% decrease over prior quarter Net sales of $438.0 …

Distribution channels: Business & Economy, Mining Industry ...

Published on November 5, 2019 - 21:05 GMT

Akcea Reports Financial Results and Highlights for Third Quarter 2019

Reported Third Quarter 2019 Global Net Product Revenues of $12 Million WAYLIVRA® (volanesorsen) launched in the E.U. Entered into a worldwide licensing agreement with Pfizer, Inc. for AKCEA-ANGPTL3-LRx Conference Call Webcast Tuesday, November 5, 4:30 p.m. …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

VIVUS Reports Third Quarter 2019 Financial Results

CAMPBELL, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Primo Water Announces Third Quarter Financial Results

Reports Third Quarter 2019 Net Sales Growth of 6.4%, at High-End of Company Expectations WINSTON-SALEM, N.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Primo Water Corporation (Nasdaq: PRMW) today reported financial results for the third quarter and nine months …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Arbor Realty Trust, Inc. Announces Proposed Private Offering of Convertible Senior Notes due 2022

UNIONDALE, N.Y., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (the “Company”) (NYSE: ABR) today announced that it intends to offer, subject to market and other conditions, $215 million in aggregate principal amount of Convertible Senior Notes …

Distribution channels: Media, Advertising & PR, Real Estate & Property Management ...

Published on November 5, 2019 - 21:05 GMT

IRIDEX to Present at the 2019 Stifel Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York City. David I. Bruce, IRIDEX’s President and Chief …

Distribution channels:

Published on November 5, 2019 - 21:05 GMT

Radius Health Announces Third Quarter 2019 Results and Corporate Update

TYMLOS U.S. net sales grew to $47M and is capturing half of anabolic new patient starts1 Guidance for FY 2019 sales increased to $168-$172M (vs. $165-$170M prior) and year-end cash, cash equivalents and investments balance increased to over $130M (vs. over …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...